Cantourage

Cantourage Group SE reported its financial results for the period from July 1 to September 30 revealing a new record quarter in the company's history. The Berlin-headquartered cannabis company posted revenue of EUR 13.2 million ($14.32 million). Last month, the company announced that it had...

Luxembourg: Medical Marijuana Shortage Due To Supplier Change The medical marijuana program in Luxembourg launched in Feb 2019 and has since dealt with supply shortages. The current lack of medical marijuana (MMJ) products is attributed to the change in the cannabis flower supplier, ...

Cannabis companies in the U.S. and Canada are capitalizing on the expanding European market as attitudes toward cannabis products continue to evolve and regulatory frameworks become more favorable. That’s just one of many topics that will be discussed by top CEOs, investors, and leaders...

Cantourage Group SE (FRA:HIGH), Cannabis House and Together Pharma (TASE:TGTR) announced a partnership that makes Ugandan medical cannabis available in Poland for the first time. From the first week of December, Polish patients enrolled in the Cannabis House initiative will have access to Together...

On Friday, a Berlin startup became the first medical cannabis company to list on the Frankfurt stock exchange. After a draft of the German government's cannabis legalization measure was leaked, it seems the EU country is getting closer to setting up retail marijuana distribution,...

European medical cannabis company Cantourage has received two British government licenses that authorize the company to import medical cannabis into the UK. The company has also received the required regulatory registration to prescribe medical cannabis products to clients via a new facility,...

Berlin-based medical cannabis company Cantourage and Israeli medical cannabis producer Together Pharma (TASE: TGTR) have teamed up to bring the first Ugandan medical cannabis products to Germany. Beginning on Wednesday, pharmacies and patients throughout Germany will have access to two of...